Ansa Biotechnologies

formerly Ansa

Next-generation DNA synthesis using enzymes

Emeryville, United States · Founded 2018 · $132.6M raised

Employees
51–200
Founded
2018
Business Model
B2B
Total Funding
$132.6M
Last Round
$54.4M Series BOct 2025
Rounds
5

About

Ansa Biotechnologies is developing a new way to make DNA that will be faster, cleaner, and more accurate than existing methods. Currently, DNA is manufactured via a chemical method that has remained mostly unchanged for 35 years. Our enzyme-based approach promises to dramatically accelerate innovation in biological research and biotechnology, including therapeutics, diagnostics and biomanufacturing.

Summary

Ansa Biotechnologies is a Biotech company based in Emeryville, United States, founded in 2018. It has raised $132.6M in total across 5 rounds, most recently a $54.4M Series B round in Oct 2025. Investors include Fifty Years, Horizons Ventures and Cerberus Ventures.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series BSeries BOct 2025
$54.4M

Sign up to see all 5 rounds

Pre-Seed through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Ansa Biotechnologies on Indexed.vc
<a href="https://indexed.vc/companies/ansabio"><img src="https://indexed.vc/api/badge/company/ansabio" alt="Ansa Biotechnologies on Indexed.vc" width="260" height="76" /></a>